BeiGene Expands Collaboration with Novartis to Develop and
https://ir.beigene.com/news/beigene-expands-collaboration-with-novartis-to-develop-and-commercialize-beigene-s-tigit-inhibitor-and-market-five/90967044-2f65-4774-942e-7edbdc880f12/
webDec 20, 2021 · BASEL, Switzerland & CAMBRIDGE, Mass. & BEIJING -- (BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced an option, collaboration and license agreement with Novartis Pharma AG to develop, manufacture and commercialize …
DA: 21 PA: 26 MOZ Rank: 24